Coronavirus Treatment: This Common Drug Found In Many Hospitals Can Be Repurposed To Reduce COVID-19 Deaths ibtimes.com/coronavirus-tr…
According to the new research, tissue plasminogen activator a.k.a. tPA , a common drug found in several hospitals, can be repurposed to alleviate the pressure on intensive care units and ventilator devices.
tPA is a kind of protein used by doctors to break up blood clots in people suffering from a heart attack or stroke.
Per the initial data from COVID-19 patients in China and Italy, blood clotting, especially in the lungs is one of the main causes of death among the critically ill
Per the initial data from COVID-19 patients in China and Italy, blood clotting, especially in the lungs is one of the main causes of death among the critically ill
The study published in the Journal of Trauma and Acute Care Surgery could help doctors reduce the significant strain on lifesaving devices including ventilators which are facing a serious shortage during this pandemic.
Per recent reports, 80% of COVID-19 patients will go through only mild to moderate symptoms and won't even need to be hospitalized. Whereas, some others who might really need hospitalization could be experiencing severe symptoms and their condition could even be life-threatening.
